The Brain Computer Interface (BCI) industry is growing at a record pace, with an estimated TAM of $400B in the US alone and plenty of
Event Details
The Brain Computer Interface (BCI) industry is growing at a record pace, with an estimated TAM of $400B in the US alone and plenty of room to grow. However, many barriers to commercialization and adoption still exist, one of which is the availability of low-cost, scalable manufacturing with clinical-grade quality. Next generation medical devices require unique consideration of materials, packaging, hermiticity, etc., not often found in standard MEMS foundries, forcing BCI companies to establish expensive internal manufacturing capabilities, thereby extending timelines and reducing runway. In addition, high costs of prototyping further discourage innovation at all technology readiness levels. Science Foundry leverages established MEMS foundry infrastructure and our own internal medical device manufacturing expertise to enable companies at the forefront of technology. Through custom process development, post-CMOS processing, or off-the-shelf neural probe offerings, we aim to accelerate commercialization timelines and lower barriers to widespread adoption of BCI technologies.